Chuang Qi

1.2k total citations · 1 hit paper
38 papers, 502 citations indexed

About

Chuang Qi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Chuang Qi has authored 38 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Chuang Qi's work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (7 papers). Chuang Qi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Genomics and Diagnostics (7 papers). Chuang Qi collaborates with scholars based in China and United States. Chuang Qi's co-authors include Yuzi Zhang, Guoqiang Wang, Jia Song, Shiqing Chen, Zhijie Wang, Yuezong Bai, Longgang Cui, Feng Sun, Qīng Wáng and Shangli Cai and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Frontiers in Immunology.

In The Last Decade

Chuang Qi

31 papers receiving 496 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer

2019 249 citations Jianchun Duan, Longgang Cui et al. JAMA Oncology profile →

Peers

Countries citing papers authored by Chuang Qi

Since Specialization

Citations

This map shows the geographic impact of Chuang Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuang Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuang Qi more than expected).

Fields of papers citing papers by Chuang Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuang Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuang Qi. The network helps show where Chuang Qi may publish in the future.

Co-authorship network of co-authors of Chuang Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Chuang Qi. A scholar is included among the top collaborators of Chuang Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuang Qi. Chuang Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolution mechanism of electrochemical and thermal stability for lithium-ion batteries after vehicle service: A comparative analysis on four different batteries 2025 ·Journal of Energy Storage ·Chunjing Lin, (unknown), (unknown), Li Lao, Yongjun Tian, Chuang Qi, (unknown), Lei Liu	0
2	A study of expansion force propagation characteristics and early warning feasibility for the thermal diffusion process of lithium-ion battery modules 2024 ·Journal of Energy Storage ·(unknown), (unknown), (unknown), (unknown), Chuang Qi, Ju Yang, Xuning Feng	10
3	The novel circ_0004674/miR‐139‐5p/ZBTB2 regulatory cascade inhibits the development of oral squamous cell carcinoma 2024 ·Head & Neck ·Chuang Qi, Lu Zhang, (unknown)	1
4	Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments 2024 ·npj Precision Oncology ·Shen Lao, Zisheng Chen, Wei Wang, (unknown), Shan Xiong, Ping He, Huan Yi, Jianfu Li, Feng Li, (unknown), Miao He, Xiaoyan Liu, Chuang Qi, Jianxing He, Wenhua Liang	1
5	Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma 2023 ·Investigational New Drugs ·Shiqi Hu, Yaqin Liu, Qidong Yang, Lin Chen, (unknown), Mingzhe Xiao, Chuang Qi, Wei Qiu	0
6	Homologous recombination-related (HRR) gene mutations in patients with glioma and their relevance to genomic characteristics, tumor mutation burden (TMB), and prognosis. 2023 ·Journal of Clinical Oncology ·Zhiming Zheng, Mengmeng Li, Qin Zhang, (unknown), (unknown), (unknown), Chuang Qi	0
7	Gastrointestinal signet ring cell malignancy: current advancement and future prospects 2023 ·Investigational New Drugs ·(unknown), (unknown), Yuan Tan, Qianqian Duan, Qin Zhang, Dongsheng Chen, Chuang Qi, Da Wang	1
8	Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD) 2022 ·International Journal of COPD ·Hongxia Ma, Qian Zhang, Yanwen Zhao, Yaohui Zhang, Jingjing Zhang, Guoqing Chen, Yuan Tan, Qin Zhang, Qianqian Duan, Tingting Sun, Chuang Qi, Fengsen Li	6
9	Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors 2022 ·Frontiers in Oncology ·(unknown), Yutong Wang, Hongxia Li, Jing Meng, Xia You, Xiaofeng Zhu, Qin Zhang, Tingting Sun, Chuang Qi, Guangyu An, Ying Fan, Binghe Xu	5
10	Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma 2022 ·Journal of Cancer Research and Clinical Oncology ·Peng Li, (unknown), (unknown), (unknown), (unknown), Xiaofeng Zhu, Yunpeng Xuan, Mengmeng Li, Jinlong Li, Minghui Ge, Tingting Sun, Chuang Qi, Yongjie Wang	5
11	The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Ye Gao, Yaqing Wu, (unknown), (unknown), Tingting Sun, Rongjie Tao, Chuang Qi, (unknown), Shuanghu Yuan	9
12	NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer 2022 ·Frontiers in Immunology ·(unknown), Haibin Chen, Liqing Zhang, Dongsheng Chen, Wang Li, Donghui Chen, Jin Xu, (unknown), Lele Zhao, Xue Song, Mingzhe Xiao, Wanglong Deng, Chuang Qi, Xuerong Wang, Xi Chen	8
13	NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma 2022 ·Frontiers in Immunology ·Hongxia Li, Qin Zhang, Qianqian Duan, Yuan Tan, Tingting Sun, Chuang Qi	9
14	PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer 2022 ·Cell Proliferation ·(unknown), Lele Zhao, Jianchun Duan, Hua Bai, Dongsheng Chen, Si Li, (unknown), Mingzhe Xiao, Qin Zhang, Qianqian Duan, Tingting Sun, Chuang Qi, Jie Wang, Zhijie Wang	7
15	Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab 2021 ·Investigational New Drugs ·Yong Wang, Jun Xu, (unknown), Chuang Qi, Rongjie Tao	3
16	Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients 2021 ·Frontiers in Oncology ·(unknown), Xiaofeng Lu, Qin Liu, (unknown), Song Liu, Fangcen Liu, Yao Fu, Xiangshan Fan, Yang Yang, Chuang Qi, Yangyang Yu, Wenxian Guan, Baorui Liu	6
17	A retrospective study of low-dose apatinib combined with S-1 in patients with advanced non-small cell lung cancer 2019 ·Journal of Thoracic Disease ·Tong Zhou, Changling Wu, Changsong Zhang, Peng Li, Hua‐Jie Dong, Xiaoyue Zhou, (unknown), Chuang Qi, Ling Yang	9
18	Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer breakdown → 2019 ·JAMA Oncology ·Jianchun Duan, Longgang Cui, Xiaochen Zhao, Hua Bai, Shangli Cai, Guoqiang Wang, Zhengyi Zhao, Jing Zhao, Shiqing Chen, Jia Song, Chuang Qi, Qīng Wáng, Mengli Huang, Yuzi Zhang, Depei Huang, Yuezong Bai, Feng Sun, J. Jack Lee, Zhijie Wang, Jie Wang	249
19	Decrease in DNA methylation 1 (DDM1) is required for the formation of ^mCHH islands in maize 2018 ·Journal of Integrative Plant Biology ·(unknown), (unknown), (unknown), (unknown), Yazhong Wang, Chuang Qi, Yan He	33
20	EGFR L747P mutation in one lung adenocarcinoma patient responded to afatinib treatment: a case report 2018 ·Journal of Thoracic Disease ·Tong Zhou, Xiaoyue Zhou, Peng Li, Chuang Qi, Ling Yang	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact